日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Low-dose "metronomic chemotherapy" with oral cyclophosphamide and methotrexate in metastatic breast cancer: a case report of extraordinarily prolonged clinical benefit

低剂量“节律化疗”(口服环磷酰胺和甲氨蝶呤)治疗转移性乳腺癌:一例临床疗效显著延长的病例报告

Masci, G; Losurdo, A; Gandini, C; Garassino, I; di Tommaso, L; Torrisi, R; Zuradelli, M; Santoro, A

Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.

cMET表达在接受EGFR酪氨酸激酶抑制剂治疗的非小细胞肺癌患者中的作用

Zucali P A, Ruiz M G, Giovannetti E, Destro A, Varella-Garcia M, Floor K, Ceresoli G L, Rodriguez J A, Garassino I, Comoglio P, Roncalli M, Santoro A, Giaccone G